| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,068 | 0,132 | 24.10. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | QLIFE HOLDING AB: Qlife receives ISO 13485 certification specifically covering at-home testing for Phenylalanine (PHE) | 2 | Cision News | ||
| 14.10. | QLife Holding AB: Qlife Secures U.S. Patent Approval for Core Egoo Platform Technology, Strengthening Global Partnering Position | 211 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") today announces that the United States Patent and Trademark Office (USPTO) has approved the Company's U.S. patent application covering core Egoo platform... ► Artikel lesen | |
| 07.10. | QLife Holding AB: Bulletin from Extraordinary General Meeting 2026 of Qlife Holding AB | 230 | GlobeNewswire (Europe) | Qlife Holding AB (the "Company" or "Qlife") held an Extraordinary General Meeting on 7 October 2026, at which the following resolutions were adopted.
Resolution on change of auditor
It was resolved... ► Artikel lesen | |
| QLIFE Aktie jetzt für 0€ handeln | |||||
| 29.09. | QLIFE HOLDING AB: Qlife Completes Customer-Funded Feasibility Study and Evaluates Potential Next Development Phase | 1 | Cision News | ||
| 17.09. | Notice of Extraordinary General Meeting 2026 in Qlife Holding AB - Resolution on change of auditing firm | 1 | Cision News | ||
| 26.08. | Qlife Holding AB Q2 Loss Decreases | 2 | RTTNews | ||
| 26.08. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q2, April - June 2026 | 196 | GlobeNewswire (Europe) | Building Momentum Through Partnerships and Innovation
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - second... ► Artikel lesen | |
| 17.07. | QLife Holding AB: Qlife Holding AB - Business Update, First Half of 2026 | 317 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") is pleased to provide a business update for the first half of 2026. During the period, the Company has continued to advance multiple strategic partnership... ► Artikel lesen | |
| 01.06. | QLife Holding AB: Qlife enters fully funded feasibility agreement with global pharma company for Egoo Health biomarker application | 229 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, announces that it has entered into a feasibility agreement with a global pharmaceutical company with the objective... ► Artikel lesen | |
| 27.05. | QLife Holding AB: Bulletin from the Annual General Meeting 2026 of Qlife Holding AB | 204 | GlobeNewswire (Europe) | Qlife Holding AB held its Annual General Meeting on 27 May 2026. At the meeting, the following resolutions were made.
The English text is an unofficial translation. In case of any discrepancies between... ► Artikel lesen | |
| 13.05. | Qlife Holding AB Q1 Sales Decline | 1 | RTTNews | ||
| 13.05. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January - March 2026 | 232 | GlobeNewswire (Europe) | Approaching strategic partnerships
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - first quarter 2026
Revenue... ► Artikel lesen | |
| 07.04. | New last trading day for paid subscription shares (BTA) of QLife Holding AB | 234 | GlobeNewswire | At the request of QLife Holding AB, the last trading day in QLife Holding AB's paid subscription shares will be changed from 2026-04-10 to 2026-04-08.
Instrument:
Paid subscription shares
Short... ► Artikel lesen | |
| 24.03. | QLife Holding AB: Qlife announces the outcome of the rights issue and resolves on a directed issue of shares to guarantors | 306 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 17.03. | QLife Holding AB: Qlife provides business update on clinical progress, partnerships and commercialization initiatives | 469 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company"), a pioneer in clinical-grade home diagnostics, today provides a business update covering recent milestones, ongoing progress, and priorities for the coming... ► Artikel lesen | |
| 17.03. | QLife Holding AB: The subscription period in Qlife's rights issue ends on Thursday, 19 March 2026 | 258 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 13.03. | QLife Holding AB: Hipro to accelerate Egoo development and regulatory approval in China following strong interest | 326 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") today announces that, following the recently communicated strong interest from hospitals in China in evaluating the Egoo platform, its strategic partner... ► Artikel lesen | |
| 05.03. | QLife Holding AB: The subscription period in Qlife's rights issue begins today | 264 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 04.03. | QLife Holding AB: Qlife publishes information document due to upcoming rights issue | 324 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 27.02. | QLife Holding AB: Qlife announces that two investors have entered agreements to subscribe for shares if the rights issue is subscribed below approx. 51.0 percent, taking over commitments from a group of guarantors | 305 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MORE LIFE COMPANY | 0,023 | -24,84 % | XFRA NEW INSTRUMENTS AVAILABLE ON 24.08.2026 | The following instruments on XETRA do have their first trading 24.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.08.2026
Aktien
1 CA0966311064 Boardwalk Real Estate... ► Artikel lesen | |
| FRESENIUS | 46,100 | +1,75 % | Gewinner der Telekom-Allianz: 3M: Amazon-Deal | Siemens: ABB-Zahlen belasten | Fresenius: Analystenlob | SpaceX hat mit seinen Plänen in den Mobilfunkmarkt einzusteigen, Aktien aus der Branche ordentlich unter Druck gesetzt. Jetzt möchte ein Quartett rund um die Deutsche Telekom zurückschlagen. Wer gewinnt... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,11 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,860 | +0,24 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,460 | +3,27 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GENEDX | 56,08 | -0,12 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| ALIGNMENT HEALTHCARE | 8,060 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors | ||
| PRIVIA HEALTH GROUP | 22,410 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| HEARTFLOW | 56,74 | +0,05 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| CARL ZEISS MEDITEC | 35,540 | +1,25 % | 12 Prozent bessere Testleistung: Wie ZEISS das Zusammenspiel von Brillenglas und Gehirn untersucht | ||
| BILLIONTOONE | 107,65 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| CONCENTRA GROUP | 39,290 | +0,03 % | Stephens initiates Concentra stock with overweight on health model | ||
| LIFESTANCE HEALTH GROUP | 12,940 | +0,08 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PACS GROUP | 47,660 | +0,06 % | Omega Healthcare transitions 32 Florida facilities to PACS Group | ||
| GERRESHEIMER | 31,340 | -2,06 % | Gerresheimer-Aktie: Trotz der deutlichen Kurserholung noch einsteigen? | Die Gerresheimer-Aktie entwickelt sich seit dem Kurseinbruch im Februar sehr erfreulich. Notierte sie damals noch bei etwa 16 €, steht sie am Montag aktuell bei rund 30,10 €. Damit hat sich der Kurs... ► Artikel lesen |